Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • SOP – Blog Post
  • Toggle search form

SOP for Preparation of Nasal Gels and Suspensions

Posted on By

SOP for Preparation of Nasal Gels and Suspensions



Standard Operating Procedure for Preparation of Nasal Gels and Suspensions

1) Purpose

The purpose of this SOP is to describe the procedures for preparing nasal gels and suspensions, ensuring homogeneity, stability, and patient safety.

2) Scope

This SOP applies to all personnel involved in the formulation and preparation of nasal gels and suspensions at [Company Name].

3) Responsibilities

  • Operators: Responsible for preparing the gels and suspensions according to formulation guidelines.
  • QA: Verifies the preparation steps, ensuring compliance with quality standards.

4) Procedure

4.1 Gel Preparation

4.1.1 Raw Material Weighing

  • Weigh the required quantities of gel-forming agents (e.g., carbomer, xanthan gum).
See also  SOP for Preparing Nasal Sprays for Systemic Drug Delivery

4.1.2 Mixing and Hydration

  • Gradually add the gel-forming agent to purified water while continuously stirring to prevent clumping.
  • Allow the mixture to hydrate fully, stirring until a uniform gel is formed.

4.2 Suspension Preparation

4.2.1 Weighing Suspended Solids

  • Weigh the solid components to be suspended (e.g., APIs) as per formulation requirements.

4.2.2 Dispersion

  • Disperse the solids in the gel base or a suitable suspending agent while ensuring even distribution.

4.3 pH and Viscosity Testing

4.3.1 pH Testing

  • Measure the pH of the formulation and adjust using dilute acid or base to achieve the target pH.

4.3.2

Viscosity Testing
  • Test the viscosity of the nasal gel or suspension using a viscometer, ensuring it meets the formulation specifications.

4.4 Sterilization and Packaging

4.4.1 Filtration and Sterilization

  • If the formulation is preservative-free, filter the suspension through a 0.22-micron filter.

4.4.2 Packaging

  • Transfer the sterile formulation into sterilized nasal spray containers or tubes for gels.

4.5 Documentation

  • Document all preparation steps, including pH and viscosity values, in the batch manufacturing record (BMR).

5) Abbreviations, if any

  • QA: Quality Assurance
  • BMR: Batch Manufacturing Record

6) Documents, if any

  • Batch Manufacturing Record (BMR)
  • pH and Viscosity Log

7) References, if any

  • USP 39 – Viscosity Standards for Gels

8) SOP Version

Version 1.0

Annexure

pH and Viscosity Log Template

Date Formulation pH Viscosity (cP) Operator Initials QA Approval
DD/MM/YYYY Formulation Name pH Value Viscosity Operator Name QA Name
           


Nasal Spray Formulations Tags:Cleaning SOP for nasal spray equipment, Environmental control in nasal spray production, Equipment maintenance for nasal sprays, Formulating isotonic nasal sprays, Microbial stability in nasal formulations, Mixing SOP for nasal formulations, Nasal spray API formulation, Nasal spray batch manufacturing SOP, Nasal spray filling machine operation, Nasal spray formulation process, Nasal spray GMP guidelines, Nasal spray homogenization techniques, Nasal spray manufacturing process, Nasal spray packaging SOP, Nasal spray preservative-free formulation, Nasal spray production SOP, Nasal spray stability studies, Nasal spray sterilization process, Nasal spray viscosity monitoring, Particle size control in nasal sprays, pH adjustment in nasal formulations, Quality control in nasal spray production, Solvent selection for nasal sprays, SOP for nasal spray manufacturing, SOP for nasal spray testing

Post navigation

Previous Post: SOP for Use of Humectants in Nasal Spray Formulations
Next Post: SOP for Homogenization Techniques in Nasal Spray Formulation

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version